Qualitative Assessment of the Brief Contact Intervention "Stay in Contact" in Suicide Prevention (EVAREST2)

October 27, 2017 updated by: Central Hospital, Nancy, France

Qualitative Assessment of the French Brief Contact Intervention "Stay in Contact" in Suicide Prevention

Background: For 40 years, brief contact interventions (BCIs) have been presented as promising approaches in suicide prevention but patient's experiences of BCIs are less investigated.

Aim: Understand mechanisms of BCIs after suicide attempt, through patient's experience of a French BCI "Stay in contact" and assess its impact on seeking care during suicidal crisis.

Method:This is a single-center, non-interventional, prospective qualitative study using phone call interview on a BCI, 6 months after suicide attempt behavior.

Statistical analysis

Data were analyzed using statistical software (Version 9.4, SAS Institute Inc., Cary, North Carolina, USA). Chi-squared test was used to assess qualitative variables and t-test to evaluate quantitative variables, with p<.05 considered significant.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The baseline interviews were conducted on the phone, on weekdays, during a mean time of 10 to 15minutes by a trained resident in psychiatry as the only interviewer. The interviewer didn't participate in patient's medical care nor in the follow-up interventions. The interviewer didn't look in patients file before conducted over the phone interviews and had only administrative information on the study subjects: first and last name, age, sex, phone number. The phone call interview wasn't considered as an intervention. Whenever the interviewer judged necessary that a patient needed more intensive treatment, the relevant referral to help was done.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Lorraine
      • Nancy, Lorraine, France, 54100
        • Central Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The "Stay in contact" program concerns patients admitted to the PED for suicide attempt and who agree to benefit from this BCI

Description

Inclusion Criteria:

  • be male or female, be aged 18 or older, have a situation permitting follow-up contacts by phone.

Exclusion Criteria:

  • be placed under supervision by the law such as guardianship and curatorship, be incarcerated and refusing to participate to the BCI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
outpatients' experiences of the BCI "Stay in contact"
Time Frame: At the closure of the BCI Stay in contact, an average of 6 months after suicide attempt
to assess the outpatients' experiences of the BCI "Stay in contact" using an hetero questionnaire completed over the phone by patients who benefited from the BCI.
At the closure of the BCI Stay in contact, an average of 6 months after suicide attempt

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Catherine Pichene, Psychiatric Emergency Departement, Central Hospital, Nancy, France
  • Principal Investigator: Fabienne Ligier, Psychiatric Emergency Departement, Central Hospital, Nancy, France
  • Principal Investigator: Sondos Abdalla, Psychiatric Emergency Departement, Central Hospital, Nancy, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2017

Primary Completion (Actual)

August 31, 2017

Study Completion (Actual)

August 31, 2017

Study Registration Dates

First Submitted

October 20, 2017

First Submitted That Met QC Criteria

October 27, 2017

First Posted (Actual)

October 30, 2017

Study Record Updates

Last Update Posted (Actual)

October 30, 2017

Last Update Submitted That Met QC Criteria

October 27, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017-A01023-50

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide and Self-harm

Clinical Trials on Over the phone interviews on the BCI "Stay in Contact"

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe